Write in a clean editor, then format for JAC-Antimicrobial Resistance in one click — DocuGuru applies the official Oxford University Press template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JAC-Antimicrobial Resistance is a peer-reviewed journal published by Oxford University Press, covering Antibiotic Use and Resistance, Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Author–year (OUP) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', JAC-Antimicrobial Resistance, 12(3), pp. 45–58.
Formats any DOI in the closest standard style — JAC-Antimicrobial Resistance has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Antibiotic Use and Resistance Antibiotic Resistance in Bacteria Antibiotics Pharmacokinetics and Efficacy Bacterial Identification and Susceptibility Testing Urinary Tract Infections Management |
| ISSN | 2632-1823 |
| Citation impact (2-yr) | 2.22 |
| h-index | 46 |
| i10-index | 360 |
| Total citations | 12,936 |
| Article processing charge | $2,200 |
| Open access | Yes |
| Top institutions publishing here | University of Oxford |
| Journal website | academic.oup.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Abstract Extended-spectrum β-lactamase (ESBL)-producing Gram-negative pathogens are a major cause of resistance to expanded-spectrum β-lactam antibiotics. Since their discovery in the early 1980s, they have spread worldwide and an are now endemic in Enterobacterales isolated from both hospital-associated and community-acquired infections. As a result, they are a global public health concern. In the past, TEM-…
These evidence-based guidelines are an updated version of those issued in 2008. They have been produced following a review of the published literature (2007-18) pertaining to the treatment of infections caused by MRSA. The guidelines update, where appropriate, previous recommendations, taking into account changes in the UK epidemiology of MRSA, ongoing national surveillance data and…
Antimicrobial resistance (AMR) is a global security threat that accounts for about 700 000 deaths annually. Studies have shown that antimicrobial resistance could result in a 2% to 3.5% reduction in global Gross Domestic Product by 2050 and a loss of between 60 and 100 trillion US dollars, worth of economic output resulting in significant…
Abstract Stenotrophomonas maltophilia is a non-fermenting, Gram-negative bacillus that has emerged as an opportunistic nosocomial pathogen. Its intrinsic multidrug resistance makes treating infections caused by S. maltophilia a great clinical challenge. Clinical management is further complicated by its molecular heterogeneity that is reflected in the uneven distribution of antibiotic resistance and virulence determinants among different…
